SCHEMBL16703383

SCHEMBL16703383

O=C(O)N1CCC(Cn2cc(-c3cn(S(=O)(=O)c4ccccc4)c4cc(F)c(F)cc34)cn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.38
TPSAB1 Q15661 1/20 0.36
TNFSF11 O14788 1/20 0.35
PDK2 Q15119 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
KDM1A O60341 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
KCNH2 Q12809 1/20 0.34
HTR2A P28223 1/20 0.34
HTR7 P34969 1/20 0.34
CTSK P43235 1/20 0.34
CTSC P53634 1/20 0.34
PDPK1 O15530 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16697679 0.89 HTR6 (0.47) HTR6
SCHEMBL16697692 0.88 HTR6 (0.46) HTR6HTR2A
SCHEMBL16698306 0.85 HTR6 (0.42) HTR6KDM1AMAOAMAOBKCNH2
SCHEMBL16697746 0.81 HTR6 (0.47) HTR6
SCHEMBL16698171 0.80 CHRM1 (0.41) HTR6CA12CA1CA2CA9
SCHEMBL16697437 0.80 PIK3C3 (0.37) HTR6KDM1AMAOAMAOBKCNH2
SCHEMBL16697923 0.80 HTR6 (0.40) HTR6CA12CA1CA2CA9
SCHEMBL16698071 0.79 HTR6 (0.40) HTR6CA12CA1CA2CA9
SCHEMBL16697770 0.79 HTR6 (0.40) HTR6HTR2AHTR7PDPK1L3MBTL1
SCHEMBL16698021 0.79 PDK2 (0.46) HTR6TNFSF11PDK2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066090-A1 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE iTeos Therapeutics (BE) 2016-09-14 EP disclosed
WO-2015067782-A1 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE ITEOS THERAPEUTICS (BE) 2015-05-14 WO disclosed